Physician profile
Edo Schaefer
NPI 1386298693
$1,583.79
in general payments reported to CMS, 2019-2025
18 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $403 · 2023: $358 · 2024: $665 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,158 · Education: $22.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.15 |
| Education | $22.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $395.90 | 2023-2025 | |
| Jazz Pharmaceuticals INC. | $293.42 | 2022-2024 | |
| Sobi, INC | $240.88 | 2022-2024 | |
| Csl Behring | $145.07 | 2022-2024 | Hemgenix |
| Genzyme Corporation | $76.75 | 2025 | |
| Hema Biologics, LLC | $52.90 | 2023 | Sevenfact |
| Apellis Pharmaceuticals, INC. | $48.64 | 2023 | Empaveli |
| Pfizer INC. | $44.92 | 2023 | |
| Servier Pharmaceuticals LLC | $40.87 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.18 | 2022-2024 | Takhzyro |
| Alexion Pharmaceuticals, INC. | $32.77 | 2024 | Ultomiris |
| Global Blood Therapeutics, INC. | $31.48 | 2022 | |
| Grifols USA, LLC | $29.52 | 2023 | Thrombate III |
| Medunik USA INC. | $25.06 | 2024 | Siklos |
| Incyte Corporation | $24.48 | 2024 | Jakafi |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $21.02 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $20.99 | 2023 | |
| Bio Products Laboratory USA, INC. | $18.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edo Schaefer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.